Balmazujvaros, Hungary

Szabolcs Struba

This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Assia Chemical Industries Ltd.. Active years: 2021.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Szabolcs Struba. Retrieved from https://idiyas.com/inventor/szabolcs-struba

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 9.0

ph-index = 1


Company Filing History:


Years Active: 2021

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Szabolcs Struba

Introduction

Szabolcs Struba is a notable inventor based in Balmazújváros, Hungary. He has made significant contributions to the field of chemistry, particularly in the development of pharmaceutical compounds. His work has led to advancements in the preparation of Venetoclax, a drug used in cancer treatment.

Latest Patents

Szabolcs Struba holds a patent for "Solid state forms of Venetoclax and processes for preparation of Venetoclax." This patent discloses processes for the preparation of Venetoclax and the Venetoclax produced by these processes. Additionally, it includes intermediate compounds used in these processes, specifically the compound of formula 5. He has 1 patent to his name.

Career Highlights

Struba is associated with Assia Chemical Industries Ltd., where he applies his expertise in chemical processes and pharmaceutical development. His work at the company has been instrumental in advancing the production methods for important medicinal compounds.

Collaborations

He has collaborated with several professionals in his field, including Zsuzsa Potarine Juhasz and Csilla Nemethne Racz. These collaborations have contributed to the successful development of his patented processes.

Conclusion

Szabolcs Struba's innovative work in the preparation of Venetoclax showcases his dedication to advancing pharmaceutical chemistry. His contributions are significant in the ongoing efforts to improve cancer treatment options.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…